1 / 24

H. M. Staudacher, K. Whelan, P. M. Irving & M. C. E. Lomer Presented by Victoria Scholl

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. H. M. Staudacher, K. Whelan, P. M. Irving & M. C. E. Lomer Presented by Victoria Scholl. Irritable Bowel Syndrome.

geneva
Download Presentation

H. M. Staudacher, K. Whelan, P. M. Irving & M. C. E. Lomer Presented by Victoria Scholl

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Comparison of symptom response following advice for adiet low in fermentable carbohydrates (FODMAPs) versusstandard dietary advice in patients with irritable bowelsyndrome H. M. Staudacher, K. Whelan, P. M. Irving & M. C. E. Lomer Presented by Victoria Scholl

  2. Irritable Bowel Syndrome • Most common gastrointestinal condition • Most commonly diagnosed in women and patients under 50 • Assessment based on Rome III criteria/NICE Criteria • No biochemical, histopathological or radiological diagnostic test for IBS exists • Symptoms include: constipation, diarrhea, abdominal pain and distention.

  3. IBS • The condition usually causes long-term symptoms • May occur in episodes. • Symptoms vary and may be meal-related. • Symptoms interfere with daily life and social functioning in many patients. • Symptoms sometimes seem to develop as a consequence of a severe intestinal infection or to be precipitated by major life events, or in a period of considerable stress.

  4. Pathogenesis • IBS patients present with GI complaints which physicians can find no organic cause • Brain-gut interaction • Heritability/Genetics • Dietary and intestinal flora • Abnormalities in neuroendocrine system of the gut

  5. Management of IBS • Pharmacotherapy: • No drug fits all • Antispasmodics • Antidepressants • Anti diarrhea agents • Antibiotics • Alternative Therapies • Aloe • Peppermint oil • probiotics • Fiber • IBS-D • IBS-C

  6. Why research on IBS is important • Quality of life • Current health care costs to manage IBS • Ability to cope with symptoms more effectively • Research into dietary management of symptoms is promising

  7. FODMAPs • Stands for: Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. • These are short chain carbohydrates that are poorly absorbed in the small intestine • This malabsorption is common to everyone however, with altered gut flora, motility disorders, and hypersensitivity in IBS, the outcome can induce symptoms.

  8. Low-FODMAP Diet • Reduction in high fructan foods (e.g. wheat, onion) and substitution with wheat free and other low fructan alternatives • Reduction in high galactooligosaccharide foods (e.g. chickpeas, lentils) • Reduction in high polyol foods and avoid polyol-sweetened sources- Replace with suitable fruits and vegetables • In those with lactose malabsorption, reduction in high lactose foods (e.g. milk, yoghurt) by restricting volume in one sitting or substitution with lactose free products. • In those with fructose malabsorption, reduction in excess fructose foods (e.g. honey)

  9. NICE Guidelines • Healthy eating principles (e.g. regular eating, taking time to eat). • Limit high fat foods, ensure a good intake of non caffeinated fluids, limit fizzy drinks • Limit insoluble fiber for diarrhea and increase gradually for constipation • Limit sugar free sweets and foods containing sorbitol • Limit fruit to 3 portions a day • Avoiding resistant starch may be useful (e.g. pulses, sweet corn, green bananas, part-baked and reheated bread) • Addition of oats and linseeds may be helpful

  10. Purpose • To compare the clinical effectiveness of a low-FODMAP diet with the standard NICE guidelines for dietary therapy for IBS.

  11. Materials and Methods • low-FODMAP dietetic service established with the assistance of a dietitian • Resources tailored to the UK context • Dietitians working in secondary and primary care trained in delivering low-FODMAP dietary advice.

  12. Materials and Methods: Study Population • A total of 82 patients completed the study • n=39 standard group, n=43 low-FODMAP group • Consecutive adult patients returning for a follow up dietetic outpatient visit were included • Common to all patients selected: • diagnosed with IBS by primary care physician/gastroenterologist • Had been referred for dietary advice • Seen by a dietitian within the previous 2-6 months

  13. Materials and Methods: Participants • Symptoms, dietary assessments and diet history's were assessed for all participants • The same group of dietitians were used throughout the study • Patients seen prior to June 2009 were placed in the “Standard” group. • Patients seen after implementation of low-FODMAP diet were placed in the low-FODMAP group.

  14. Materials and Methods: Intervention • Fructooligosaccharides, galactooligosaccharides and polyols were restricted in all patients • 9 month evaluation period • Written information was given to both groups at initial consultation was specific to the dietary advice given. • Standard group= 2 page written resource • Low-FODMAP group= color booklet

  15. Questionnaire • 16 point questionnaire • Verbal responses were collected regarding symptom change and satisfaction • Likert scale taken from validated IBS Global Improvement Scale was used to rate symptom change • Four point statements relating to satisfaction with symptom response were also asked • All answers were anonymous and confidential

  16. Statistical Analysis • Data analyzed using SPSS • Descriptive statistics for demographic data, baseline symptom comparisons, and types of standard dietary advice • Chi-squared test- symptom response and satisfaction comparison between groups • Symptoms responses collapsed into improved and not improved • Magnitude of improvement response collapsed into : worsened, no change, slightly improved, moderately improved, substantially improved.

  17. Results: Symptom change • More patients in the low-FODMAP group reported improvements in bloating, abdominal pain, and flatulence compared to standard. • low-FODMAP group less likely to report deterioration or lack of improvement for symptoms than standard. • More patients in low-FODMAP group reported symptom improvements for diarrhea • No significant difference in proportion of participants reporting improvements in constipation between groups • More patients in the low-FODMAP group had improvements in nausea and energy levels

  18. Satisfaction with symptom response and dietary advice • 76% of patients in low-FODMAP group reported satisfaction with symptom response compared to 54% in standard dietary advice group • There was no difference between groups in ease of understanding of written information • More patients in low-FODMAP group showed interest in implementing further change to their diet than standard group • Most patients reported following the diet strictly • Symptom resolution mean time= 3.5 weeks.

  19. Discussion • More patients in the low-FODMAP group reported satisfaction with symptom response • There was a better overall symptom response in low-FODMAP group • More patients in the low-FODMAP group reported improvements in bloating, flatulence, and abdominal pain compared to standard.

  20. Strengths and Weaknesses • Weaknesses • No random selection • No assessment of dietary intake • Medications/ change in use of medications not recorded • Probiotic intake not recorded • Multiple dietitians conducting interviews- differing ways to communicate information • Overlap between diets • Strengths • Used dietitians • Gave participants information to take • home with them • Individual assessment of each symptom • Patients were similar at baseline • Use of a control group

  21. Conclusion and Implications for Future Research • This study suggests that a low-FODMAP diet may be more effective than standard dietary advice for the management of IBS symptoms. • Future research on implementation and patient efficacy of a low-FODMAP diet is needed. • Implementation of a low-FODMAP diet in American patients still needed. • Studies on reintroducing low-FODMAP foods after a period of exclusion needed.

  22. Questions???? • Judith-  ”I know that this is a completely different disease, but I am curious if in your research you found that any IBS sufferers experience cyclic symptoms and if so do you believe this is diet related? If so could this be due to the vegetables/fruits that are in season?” • Aubrey- “While Likert scales have been validated and effective, do you think there are any other questionnaire or collection methods that would have been more efficient? I thought that maybe food diaries would have been helpful for the RD's so they could track patient diets and make sure they were consuming the right foods.” • Kirstie- “In this study they stated that fiber intake was not recorded.  Do you think that recording fiber intake would have changed the results of the study?”

  23. Questions??? • Sarah E.-  ”Could this "diet" work for other stomach/intestine/colon issues such as after gastric bypass surgery to prevent bloating, or fiber-related advice after diverticulitis surgery?” • Sarah S. “Do you know if this diet is implemented anywhere in the US? If not, can you see this becoming more of a “standard” diet prescription for individuals with IBS who do not see improvement with a standard nutrition prescription?” • Katie-  Do you think patients in the U.S. would have a difficult time following a low FODMAP diet??

  24. References • 1. Chirila I, Petrariu FD, Ciortescu I, Mihai C, Drug VL. Diet and irritable bowel syndrome. J Gastrointestin Liver Dis. Vol 21. Romania2012:357-362.Acessed March 10,2013 • 2. El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. Oct 7 2012;18(37):5151-5163. Acessed March 10,2013 • 3. Occhipinti K, Smith JW. Irritable bowel syndrome: a review and update. Clin Colon Rectal Surg. Vol 25. United States2012:46-52.Accessed March 20, 2013 • 4. Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. Vol 62. England2013:159-176. Acessed April 1,2013 • 5. Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. Vol 142. United States2012:1510-1518.March 20, 2013 • 6. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. Oct 2011;24(5):487-495.Acessed March 10,2013

More Related